Evidence map›Paper›PMID 32200759›Full record

ArticleStroke2020

Derivation and Application of a Tool to Estimate Benefits From Multiple Therapies That Reduce Recurrent Stroke Risk.

Adam Richards, Nicholas J Jackson, Eric M Cheng, Robert J Bryg, Arleen Brown, Amytis Towfighi, Nerses Sanossian, Frances Barry, Ning Li, Barbara G Vickrey

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Stroke, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00861081 (RCT of an Intervention to Enable Stroke Survivors in Los Angeles County Hospitals to "Stay Within the Guidelines"), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00861081 nacompletednot on this map

RCT of an Intervention to Enable Stroke Survivors in Los Angeles County Hospitals to "Stay Within the Guidelines" (SUSTAIN)

TypeinterventionalSponsorUniversity of California, Los AngelesRan2010 to 2013Enrolled410ConditionsStrokeArmsCare Management, Written Materials
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Adam RichardsFrom the UCLA David Geffen School of Medicine, Los Angeles, CA (A.R., N.J.J., E.M.C., A.B., F.B., N.L.).
Nicholas J JacksonFrom the UCLA David Geffen School of Medicine, Los Angeles, CA (A.R., N.J.J., E.M.C., A.B., F.B., N.L.).
Eric M ChengFrom the UCLA David Geffen School of Medicine, Los Angeles, CA (A.R., N.J.J., E.M.C., A.B., F.B., N.L.).
Robert J BrygOlive View-UCLA Medical Center, Sylmar, CA (R.J.B., A.B.).
Arleen BrownFrom the UCLA David Geffen School of Medicine, Los Angeles, CA (A.R., N.J.J., E.M.C., A.B., F.B., N.L.).
Amytis TowfighiRancho Los Amigos National Rehabilitation Center, Downey, CA (A.T.).
Nerses SanossianKeck School of Medicine of USC, Los Angeles, CA (N.S.).
Frances BarryFrom the UCLA David Geffen School of Medicine, Los Angeles, CA (A.R., N.J.J., E.M.C., A.B., F.B., N.L.).
Ning LiFrom the UCLA David Geffen School of Medicine, Los Angeles, CA (A.R., N.J.J., E.M.C., A.B., F.B., N.L.).
Barbara G VickreyIcahn School of Medicine at Mount Sinai, New York, NY (B.G.V.).
University of California, Los Angeles · USKeck Hospital of USC · USOlive View-UCLA Medical Center · USRancho Los Amigos National Rehabilitation Center · US

Funding

Secondary Stroke prevention by Uniting Community and Chronic care model teams Early to End Disparities: the SUCCEED TrialU54NS081764 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TOWFIGHI, AMYTIS · 2012 to 2016
$11.3M
The Development and Implementation of a Culturally-Congruent Educational Film designed for PLWHIV to Address Patients' Trauma Histories, Barriers to Care, and CVD Risk ReductionU01HL142109 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BROWN, ARLEEN F., HAMILTON, ALISON B. · 2018 to 2021
$3.8M
NHLBI NIH HHS U01 HL142109NINDS NIH HHS U54 NS081764
6 · The paper itself

Abstract

Background and Purpose- Lowering blood pressure and cholesterol, antiplatelet/antithrombotic use, and smoking cessation reduce risk of recurrent stroke. However, gaps in risk factor control among stroke survivors warrant development and evaluation of alternative care delivery models that aim to simultaneously improve multiple risk factors. Randomized trials of care delivery models are rarely of sufficient duration or size to be powered for low-frequency outcomes such as observed recurrent stroke. This creates a need for tools to estimate how changes across multiple stroke risk factors reduce risk of recurrent stroke. Methods- We reviewed existing evidence of the efficacy of interventions addressing blood pressure reduction, cholesterol lowering, antiplatelet/antithrombotic use, and smoking cessation and extracted relative risks for each intervention. From this, we developed a tool to estimate reductions in recurrent stroke risk, using bootstrapping and simulation methods. We also calculated a modified Global Outcome Score representing the proportion of potential benefit (relative risk reduction) achieved if all 4 individual risk factors were optimally controlled. We applied the tool to estimate stroke risk reduction among 275 participants with complete 12-month follow-up data from a recently published randomized trial of a healthcare delivery model that targeted multiple stroke risk factors. Results- The recurrent stroke risk tool was feasible to apply, yielding an estimated reduction in the relative risk of ischemic stroke of 0.36 in both the experimental and usual care trial arms. Global Outcome Score results suggest that participants in both arms likely averted, on average, 45% of recurrent stroke events that could possibly have been prevented through maximal implementation of interventions for all 4 individual risk factors. Conclusions- A stroke risk reduction tool facilitates estimation of the combined impact on vascular risk of improvements in multiple stroke risk factors and provides a summary outcome for studies testing alternative care models to prevent recurrent stroke. Registration- URL: https://www.clinicaltrials.gov; Unique identifier: NCT00861081.

Indexed as

Smoking CessationAgedAnticholesteremic AgentsAnticoagulantsAntihypertensive AgentsAspirinDiet TherapyExerciseFemaleHumansHydroxymethylglutaryl-CoA Reductase InhibitorsMaleMiddle AgedPlatelet Aggregation InhibitorsPrognosisRecurrenceAnticholesteremic AgentsAnticoagulantsAntihypertensive AgentsAspirinHydroxymethylglutaryl-CoA Reductase InhibitorsPlatelet Aggregation InhibitorsWarfarincardiovascular diseaseshealth services researchhumansoutcome assessment health carestroke

Identifiers

PMID32200759
PMCPMC7185059
OpenAlexW3012577465

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.